Viewing Study NCT05487703


Ignite Creation Date: 2025-12-24 @ 7:37 PM
Ignite Modification Date: 2025-12-25 @ 5:18 PM
Study NCT ID: NCT05487703
Status: COMPLETED
Last Update Posted: 2024-10-08
First Post: 2022-08-02
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Study To Describe The Use Of Tofacitinib After Use Of Rituximab In Patients With Rheumatoid Arthritis In A Real-World Setting
Sponsor: Pfizer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-11-14
Start Date Type: ACTUAL
Primary Completion Date: 2022-12-23
Primary Completion Date Type: ACTUAL
Completion Date: 2022-12-23
Completion Date Type: ACTUAL
First Submit Date: 2022-08-02
First Submit QC Date: None
Study First Post Date: 2022-08-04
Study First Post Date Type: ACTUAL
Results First Submit Date: 2023-12-06
Results First Submit QC Date: None
Results First Post Date: 2024-10-08
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-07-05
Last Update Post Date: 2024-10-08
Last Update Post Date Type: ACTUAL